选择尺寸
| 致您/货号 | 是否有货 | 价格 |
|---|---|---|
5 g | 预计今天发货发货地SIGMA ALDRICH Pte Ltd | $232.00 |
25 g | 预计发货时间2026年6月16日发货地SIGMA ALDRICH Pte Ltd | $928.00 |
关于此项目
$232.00
预计今天发货详情
Quality Segment
description
RTECS - FF2200000
assay
≥98% (titration)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, desiccated
color
white
solubility
aqueous buffer: 2-5 mg/mL, water: 2-5 mg/mL
shipped in
ambient
storage temp.
−20°C
SMILES string
Cl.N(CCCN(CC)C#N)(C)C
InChI
1S/C8H17N3.ClH/c1-4-11(8-9)7-5-6-10(2)3;/h4-7H2,1-3H3;1H
InChI key
FDXPUDRRFDHONO-UHFFFAOYSA-N
General description
Packaging
Preparation Note
Other Notes
Richardson, A., et al. 1992.生物化学。Pharmacol.43, 1415.
Taniuchi, M., et al. 1986.《美国Natl.Acad.Sci. USA83, 1950.
Chase, J.W., et al. 1983.Proc.Natl.Acad.Sci. USA80, 5480.
Williams, A., et al. 1981.J. Am. Chem. Soc.103, 7090.
Yamada, H., et al. 1981.Biochemistry20, 4836.
Thomas, J.O., et al. 1978.J. Mol.Biol.123, 149.
Ozawa, H. 1970.Biochemistry9, 2158.
Kopple, K.D., et al. 1962.J. Am. Chem. Soc.84, 4457.
Legal Information
Disclaimer
1 of 1
此商品 | |||
|---|---|---|---|
| form solid | form solid | form powder | form powder |
| assay ≥98% (titration) | assay - | assay ≥98.0% (AT) | assay ≥99.0% (AT) |
| storage temp. −20°C | storage temp. −20°C (−15°C to −25°C) | storage temp. −20°C | storage temp. −20°C |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
| solubility aqueous buffer: 2-5 mg/mL, water: 2-5 mg/mL | solubility - | solubility H2O: soluble 1 gm/10 ml, clear to very slightly hazy, colorless to very faintly yellow | solubility H2O: soluble 0.2 g/L |
| color white | color - | color - | color - |
signalword
Danger
target_organs
Stomach,large intestine,lymph node
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
flash_point_f
Not applicable
flash_point_c
Not applicable
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 2 Oral





